Azizah M R, Shahnaz M, Zulkifli M N, Nasuruddin B A
Division of Immunology, Institute for Medical Research, Kuala Lumpur, Malaysia.
Malays J Pathol. 1995 Dec;17(2):83-6.
A study of 101 sera from 69 Malay, 14 Chinese and 18 Indian healthy adult Malaysians was undertaken to determine the frequency of antinuclear antibodies (ANA), antimitochondrial antibodies (AMA), antismooth muscle antibodies (SMA) and antiparietal cell antibodies (APCA). There were 67 females and 34 males with a mean age of 31.7 years (+/-8.6). ANA was assayed by immunofluorescence (IF) using both mouse liver and HEp-2 cell substrates. AMA, SMA and APCA were also tested by IF using composite sections from mouse liver, kidney and stomach substrates. Analysis showed 6.9% were positive for ANA at a titre of 1:40 with HEp-2 while only 1.9% were detected using mouse liver. 9.9% had detectable AMA from titres 1:10 to 1:90. None of them had detectable SMA and only 1 (0.09%) had APCA at a titre of 1:80. This study suggests that a diagnosis of an autoimmune disorder has to be cautiously made taking into consideration that autoantibodies are present in low titres in the healthy population.
对来自69名马来人、14名中国人和18名印度人的101份健康成年马来西亚人的血清进行了研究,以确定抗核抗体(ANA)、抗线粒体抗体(AMA)、抗平滑肌抗体(SMA)和抗壁细胞抗体(APCA)的频率。其中有67名女性和34名男性,平均年龄为31.7岁(±8.6)。ANA通过免疫荧光法(IF)使用小鼠肝脏和HEp-2细胞底物进行检测。AMA、SMA和APCA也通过IF使用来自小鼠肝脏、肾脏和胃底物的复合切片进行检测。分析显示,以HEp-2为底物时,6.9%的人ANA滴度为1:40呈阳性,而使用小鼠肝脏时仅检测到1.9%。9.9%的人AMA滴度从1:10到1:90可检测到。他们中没有人检测到SMA,只有1人(0.09%)APCA滴度为1:80。这项研究表明,考虑到健康人群中自身抗体以低滴度存在,自身免疫性疾病的诊断必须谨慎做出。